These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 5457511)
1. Antitumor efficacy of 7 beta, 17 alpha-dimethyltestosterone (Calusterone) in advanced female breast cancer. Gordan GS; Halden A; Walter RM Calif Med; 1970 Sep; 113(3):1-10. PubMed ID: 5457511 [TBL] [Abstract][Full Text] [Related]
2. [Calusterone (7-beta, 17-alpha-dimethyltestosterone) in the palliative treatment of advanced breast cancer]. Robustelli Della Cuna G; Bernardo G; Strada MR Minerva Med; 1977 Oct; 68(52):3555-63. PubMed ID: 74052 [TBL] [Abstract][Full Text] [Related]
3. Effect of 7beta, 17alpha-dimethyltestosterone (calusterone) on cortisol metabolism in women with advanced breast cancer. Fukushima DK; Zumoff B; Bulkin W; Hellman L J Clin Endocrinol Metab; 1976 Jul; 43(1):38-45. PubMed ID: 133118 [TBL] [Abstract][Full Text] [Related]
4. 7beta,17alpha-Dimethyltestosterone (calusterone)-induced changes in the metabolism, production rate, and excretion of estrogens in women with breast cancer: a possible mechanism of action. Fishman J; Hellman L J Clin Endocrinol Metab; 1976 Feb; 42(2):365-9. PubMed ID: 131130 [TBL] [Abstract][Full Text] [Related]
5. Calusterone (7beta,17alpha-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer. Gordan GS; Halden A; Horn Y; Fuery JJ; Parsons RJ; Walter RM Oncology; 1973; 28(2):138-46. PubMed ID: 4583006 [No Abstract] [Full Text] [Related]
6. Male breast cancer: two cases with objective regressions from calusterone (7 alpha, 17 beta-dimethyltestosterone) after failure of orchiectomy. Horn Y; Roof B Oncology; 1976; 33(4):188-91. PubMed ID: 190574 [TBL] [Abstract][Full Text] [Related]
7. The effect of 7beta, 17alpha-dimethyltestosterone (calusteron) on testosterone metabolism in women with advanced breast cancer. Zumoff B; Levin J; Bradlow HL; Hellman L J Clin Endocrinol Metab; 1977 Jun; 44(6):1203-5. PubMed ID: 141459 [TBL] [Abstract][Full Text] [Related]
8. [Clinical considerations on the use of a new synthetic androgen, Calusterone, in the treatment of advanced breast cancer]. de Matteis A; Perrone V; Marone A Minerva Med; 1977 Jul; 68(36):2499-504. PubMed ID: 142218 [TBL] [Abstract][Full Text] [Related]
9. Calusterone therapy for advanced breast cancer. Aslam J; Maxwell I Cancer Treat Rep; 1977; 61(3):371-3. PubMed ID: 141327 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984 [TBL] [Abstract][Full Text] [Related]
11. Calusterone. Brodkin RA; Cooper MR Ann Intern Med; 1978 Dec; 89(6):945-8. PubMed ID: 152592 [TBL] [Abstract][Full Text] [Related]
12. Leucopoietic effect of calusterone (7 beta, 17 alpha-dimethyltestosterone) in women with advanced breast cancer. Horn Y; Halden A; Gordan GS Scand J Haematol; 1973; 10(3):177-80. PubMed ID: 4768684 [No Abstract] [Full Text] [Related]
13. [Trial hormone therapy of advanced breast cancers with calusterone. Preliminary study of 41 cases]. Brule G; Chauvergne J; Clavel B; Gary-Bobo J; Gurrin J; Klein T; Pommatau E Sem Hop; 1974 Dec 8-14; 50(50-51):3099-105. PubMed ID: 4377318 [No Abstract] [Full Text] [Related]
14. Letter: Calusterone (NSC-88536) in advanced breast cancer. Falkson G; Falkson HC Cancer Treat Rep; 1976 Mar; 60(3):220-1. PubMed ID: 130973 [No Abstract] [Full Text] [Related]
15. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines. Pieńkowski T; Jagiello-Gruszfeld A Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140 [TBL] [Abstract][Full Text] [Related]
16. Calusterone treatment of breast cancer. Greenspan EM JAMA; 1972 Apr; 220(4):588. PubMed ID: 5067137 [No Abstract] [Full Text] [Related]
17. Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer. Mouridsen H; Chaudri-Ross HA Oncologist; 2004; 9(5):497-506. PubMed ID: 15477634 [TBL] [Abstract][Full Text] [Related]
18. A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma. Kubota T; Abe O; Izuo M; Watanabe H; Enomoto K; Ohsawa N; Kuno K Anticancer Res; 1993; 13(6B):2361-5. PubMed ID: 8135468 [TBL] [Abstract][Full Text] [Related]
19. [Experiences with Drostanolone-Propionate (Masterid) in metastasizing breast carcinoma]. Drings P; Fritsch H; Schmidt-Hermes HJ Ther Ggw; 1972 Apr; 111(4):547-8 passim. PubMed ID: 5029717 [No Abstract] [Full Text] [Related]
20. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients. O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]